Abstract
RIP3-dependent necroptosis has recently garnered significant interest because of the unique signaling mechanisms and pathologic functions involved in this process. Accordingly, a number of chemical screens have identified several effective small-molecule inhibitors that specifically block necroptosis. Here, we report the discovery that kongensin A (KA), a natural product isolated from Croton kongensis, is a potent inhibitor of necroptosis and an inducer of apoptosis. Using a new bioorthogonal ligation method (TQ ligation), we reveal that the direct cellular target of KA is heat shock protein 90 (HSP90). Further studies demonstrate that KA covalently binds to a previously uncharacterized cysteine 420 in the middle domain of HSP90 and dissociates HSP90 from its cochaperone CDC37, which leads to inhibition of RIP3-dependent necroptosis and promotion of apoptosis in multiple cancer cell lines. Collectively, our findings demonstrate that KA is an effective HSP90 inhibitor that has potential anti-necroptosis and anti-inflammation applications.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Phytogenic / chemistry
-
Antineoplastic Agents, Phytogenic / isolation & purification
-
Antineoplastic Agents, Phytogenic / pharmacology*
-
Apoptosis / drug effects*
-
Biological Products / chemistry
-
Biological Products / isolation & purification
-
Biological Products / pharmacology*
-
Cell Proliferation / drug effects
-
Cell Survival / drug effects
-
Croton / chemistry
-
Diterpenes / chemistry
-
Diterpenes / isolation & purification
-
Diterpenes / pharmacology*
-
Dose-Response Relationship, Drug
-
Drug Screening Assays, Antitumor
-
HSP90 Heat-Shock Proteins / antagonists & inhibitors*
-
HSP90 Heat-Shock Proteins / metabolism
-
HT29 Cells
-
HeLa Cells
-
Humans
-
Necrosis / drug therapy
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / isolation & purification
-
Protein Kinase Inhibitors / pharmacology*
-
Receptor-Interacting Protein Serine-Threonine Kinases / antagonists & inhibitors
-
Receptor-Interacting Protein Serine-Threonine Kinases / metabolism*
-
Structure-Activity Relationship
-
Tumor Cells, Cultured
Substances
-
Antineoplastic Agents, Phytogenic
-
Biological Products
-
Diterpenes
-
HSP90 Heat-Shock Proteins
-
HSP90AB1 protein, human
-
Protein Kinase Inhibitors
-
kongensin A
-
RIPK3 protein, human
-
Receptor-Interacting Protein Serine-Threonine Kinases